cases occurring in the absence of a prior caesarean are increasingly reported. This study examines whether the risk of developing MAP is increased by prior gynaecological procedures.
Background: Accurate information on causes of stillbirth is vital to guide prevention strategies and for counselling parents. This study assessed agreement between hospital and expert panel classifications of stillbirths to identify areas for improvement.
Method: This study forms part of a prospective study including all stillbirths at participating hospitals in Australia. An educational workshop (IMPROVE) was provided prior to assist in implementation of the Perinatal Society of Australia and New Zealand (PSANZ) Perinatal Mortality guidelines. Hospital committee and expert panel classification of stillbirth were conducted independently. Inter-observer agreement of the primary classification according to PSANZ Perinatal Death classification system was assessed using Cohen's kappa with 95% confidence intervals.
Results: Between 2013 and 2015, data were collated for 217 stillbirths from 12 hospitals across 6 states and territories. Over two-thirds of stillbirths occurred before labour and 24.9% were terminations of pregnancy. Placental histopathology was performed for 91.2% of stillbirths and 50% had full or limited autopsy. Substantial agreement between hospital and expert panel classifications of stillbirth was found (kappa = 0.74, 95% CI 0.64-0.76). Agreement was higher for the categories of congenital abnormality (kappa = 0.95), spontaneous preterm (kappa = 0.84) and hypertension (kappa = 0.77); and lower for antepartum haemorrhage (kappa = 0.45), perinatal infection (kappa = 0.55), fetal growth restriction (kappa = 0.56) and maternal conditions (kappa = 0.57). The use of binasal prongs to deliver nasal continuous positive airway pressure (CPAP) in very preterm infants is associated with pressure-related nasal trauma. This review summarises the evidence regarding the incidence and risk factors for nasal trauma, and strategies that might prevent it.
Conclusions
Method: Eligible studies were identified from database searches of MEDLINE (PubMed including the Cochrane Library), EMBASE, CINAHL and Scopus, and included all articles published in English prior to November 20 th , 2016.
Results: A total of 43 studies were analysed, comprising 14 randomised controlled trials, 10 observational studies, two cohort studies, seven case reports and 10 reviews. The reported incidence of nasal trauma in preterm infants ranges from 20% to 100%, with infants born less than 30 weeks' gestation and those requiring longer duration of CPAP most at risk. Strategies shown to reduce nasal trauma in preterm infants on binasal respiratory support include: the use of nasal barrier dressings (3 studies, n = 345, RR 0.27, 95% Cl 0.13-0.55), using nasal high-flow therapy as an alternative to CPAP (8 studies, n = 1640, RR 0.46, 95% Cl 0.37-0.57) and using a nasal mask rather than binasal prongs (4 studies, n = 476, RR 0.70, 95% Cl 0.51-0.94).
Conclusions: Nasal trauma is common in very preterm infants receiving CPAP via binasal prongs. There are feasible strategies to reduce nasal trauma. However, larger randomised trials are required to fully evaluate these prevention strategies before changing clinical practice. Background: Fetal growth restricted (FGR) leads to redistribution of cardiac output to survive suboptimal intrauterine conditions. Cardiovasuclar adaptations result in structural and functional changes to the developing vessels which may underlie postnatal neurological and cardiovascular sequale. Ventilation of FGR lambs with inhaled nitric oxide (iNO) improves cardiovascular output, suggesting an altered NO pathway may underpin the pathophysiology of FGR infants.
LONG-TERM MATERNAL SILDENAFIL TREATMENT INCREASES SILDENAFIL AND ENDOTHELIUM INDEPENDENT MEDIATED CEREBRAL VASODILATION IN BOTH FETAL GROWTH RESTRICTED AND APPROPRIATELY GROWN FETAL LAMBS
Sildenafil modulates the NO pathway via prevention of NO breakdown. Our study aimed to investigate the effect of intravenous maternal sildenafil administration on cardiovascular function in FGR fetuses.
Method: Fetal sheep (0.6 gestation) underwent sterile surgery for single umbilical artery ligation (SUAL, FGR) or sham (control, AG) surgery to replicate FGR. Following recovery ewes received sildenafil (40 mg/24 hrs, I.V.) or saline until 0.83 gestation. Fetuses were euthanased for collection of aorta, carotid, femoral, pulmonary and middle cerebral artery vessels. Functional assessment of vessels was conducted (in vitro wire myography) with mediators of the NO pathway.
Results: Endothelium-independent vasodilation was significantly enhanced within cerebral and systemic arteries of FGR compared to AG offspring (p < 0.05). Maternal sildenafil treatment further increased vasodilatory capacity in cerebral arteries.
Conclusions: Cerebral arteries of FGR fetuses have an increased reactivity to NO compared to AG fetuses. Maternal sildenafil administration during gestation further increased reactivity in developing fetuses. Interestingly, both AG and FGR fetuses were similarly affected by maternal sildenafil administration. Results: Preliminary analysis of one calendar month included 577 infants, with blood cultures taken and empiric antibiotic treatment in 25 (4.3%). All blood cultures were negative. Application of the NEORC would have resulted in 11 (44%) fewer infants having blood cultures taken and empiric antibiotic treatment, 3 of whom had prolonged hospital stays to receive 5 days of antibiotics.
THE EARLY ONSET RISK CALCULATOR TO EVALUATE EARLY ONSET SEPSIS IN INFANTS BORN ?35 WEEKS' GESTATION
Conclusions: Compared with a risk-based EOS guideline, the NEORC reduced the proportion of infants born ?35 weeks' gestation treated with antibiotics, without missing any cases of EOS. Analysis will continue to include a larger inception cohort as planned. Aim: To evaluate the two year physical growth of neonates who underwent colostomy.
Methods: Retrospective audit by going through medical records.
Results: A total of 21 neonates were included. The underlying condition was imperforate anus in 17, anorectal anomaly in 3 and Hirschsprung disease in 1. The median gestational age was 38 weeks (range 31-40 weeks). 8 were female and 13 were male. The median birth weight centile was 38 (15-62) whereas it was 34 (9-73) at 20 months of age at the time of second follow-up after stoma closure (p = 0.468). The median birth length centile was 47 (26-72) whereas it was 44.5 (36-55) at second follow-up after stoma closure (p = 0.878). The median birth head circumference centile was 34 (23-73) whereas it was 47 (34-72) at second followup after stoma closure (p = 0.786). The physical growth centiles were similar before and after stoma closure.
Conclusions: Physical growth of neonates undergoing colostomy was adequate in the first two years of life. Results: Four RCTs (N = 416) and five non-RCTs (N = 2562) of moderate to high quality were included. Meta-analysis using fixed effects model showed significant effects of B. breve M-16 V supplementation on various outcomes from non-RCTs: (1) Any necrotizing enterocolitis (NEC): 2 studies (n = 697); OR: 0.11 (95% CI: 0.02, 0.57); p = 0.009 (2) Late onset sepsis (LOS): 3 studies (n = 2452): OR: 0.56 (95% CI: 0.45, 0.71); p < 0.0001 (3) Mortality: 2 studies (n = 2319): OR: 0.61 (95% CI: 0.44, 0.84); p = 0.002 (4) Postnatal age at full feeds (PAFF) days: Mean Difference, 95% CI: 2 studies (n = 361):-2.42 (−2.55, −2.3); p < 0.00001. Results from RCTs showed no statistically significant beneficial effects on ? stage 2 NEC, LOS, mortality and PAFF. There was no probiotic sepsis.
BIFIDOBACTERIUM BREVE M-16V AS A PROBIOTIC FOR PRETERM INFANTS-
Conclusions: B. breve M-16 V has the potential to reduce the risk of NEC, LOS, PAFF, and mortality in preterm infants. Larger definitive RCTs are needed to confirm these findings.
